Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice-Reference-Cited by-同舟云学术

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA₂), UCM-14216, Ameliorates Spinal Cord Injury in Mice

Published:2022-08-10 Issue:16 Volume:65 Page:10956-10974
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Khiar-Fernández Nora¹,Zian Debora¹,Vázquez-Villa Henar¹^ORCID,Martínez R. Fernando¹^ORCID,Escobar-Peña Andrea¹,Foronda-Sainz Román¹,Ray Manisha²,Puigdomenech-Poch Maria³,Cincilla Giovanni⁴^ORCID,Sánchez-Martínez Melchor⁴⁵^ORCID,Kihara Yasuyuki²,Chun Jerold²,López-Vales Rubèn³^ORCID,López-Rodríguez María L.¹^ORCID,Ortega-Gutiérrez Silvia¹^ORCID

Affiliation:

1. Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid E-28040, Spain

2. Translational Neuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States

3. Departament de Biologia Cel·lular, Fisiologia i Immunologia, Institut de Neurociències, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Universitat Autònoma de Barcelona, Bellaterra, BarcelonaE-08193, Spain

4. Molomics, Barcelona Science Park, Baldiri i Reixac 4-8, Barcelona E-08028, Spain

5. Burua Scientific, Sant Pere de Ribes E-08810, Spain

Funder

National Institute of Neurological Disorders and Stroke

Comunidad de Madrid

U.S. Department of Defense

National Institute of Mental Health

Instituci? Catalana de Recerca i Estudis Avan?ats

Agencia Estatal de Investigaci?n,Ministerio de Ciencia, Innovaci?n y Universidades

Publisher

American Chemical Society (ACS)

Subject